SeaStar Medical Holding Corp Research and Development Expense
SeaStar Medical Holding Corp (ICU) reported Research and Development Expense of $2.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- SeaStar Medical Holding Corp research and development expense for the quarter ending 2026-06-30 was $2.52M, a 143.01% increase year-over-year.
- SeaStar Medical Holding Corp research and development expense for the quarter ending 2026-03-31 was $2.34M, a 3.58% decline year-over-year.
- SeaStar Medical Holding Corp research and development expense for the quarter ending 2025-12-31 was $2.20M, a 19.65% decline year-over-year.
- SeaStar Medical Holding Corp research and development expense for the quarter ending 2025-09-30 was $1.85M, a 20.80% decline year-over-year.
- SeaStar Medical Holding Corp research and development expense for fiscal 2025 was $7.52M, a 17.43% decline from fiscal 2024.
- SeaStar Medical Holding Corp research and development expense for fiscal 2024 was $9.11M, a 52.44% increase from fiscal 2023.
- SeaStar Medical Holding Corp research and development expense for fiscal 2023 was $5.97M, a 138.63% increase from fiscal 2022.
- SeaStar Medical Holding Corp research and development expense for fiscal 2022 was $2.50M, a 9.51% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.52M 10-Q · filed 2026-08-12 | $4.86M 10-Q · filed 2026-08-12 | $7.06M derived: sum of 3 quarters · filed 2026-08-12 | $8.91M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $2.34M 10-Q · filed 2026-05-13 | $4.54M derived: sum of 2 quarters · filed 2026-05-13 | $6.39M derived: sum of 3 quarters · filed 2026-05-13 | $7.43M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.05M derived: sum of 2 quarters · filed 2026-03-25 | $5.09M derived: sum of 3 quarters · filed 2026-08-12 | $7.52M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $1.85M 10-Q · filed 2025-11-13 | $2.89M derived: sum of 2 quarters · filed 2026-08-12 | $5.32M 10-Q · filed 2025-11-13 | $8.06M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $1.04M 10-Q · filed 2026-08-12 | $3.47M 10-Q · filed 2026-08-12 | $6.21M derived: sum of 3 quarters · filed 2026-08-12 | $8.54M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $2.43M 10-Q · filed 2026-05-13 | $5.17M derived: sum of 2 quarters · filed 2026-05-13 | $7.50M derived: sum of 3 quarters · filed 2026-05-13 | $9.84M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $5.07M derived: sum of 2 quarters · filed 2026-03-25 | $7.41M derived: sum of 3 quarters · filed 2026-03-25 | $9.11M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $2.34M 10-Q · filed 2025-11-13 | $4.67M derived: sum of 2 quarters · filed 2025-11-13 | $6.37M 10-Q · filed 2025-11-13 | $7.54M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.33M 10-Q · filed 2025-08-13 | $4.03M 10-Q · filed 2025-08-13 | $5.21M derived: sum of 3 quarters · filed 2025-08-13 | $6.29M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-14 | $2.87M derived: sum of 2 quarters · filed 2025-05-14 | $3.96M derived: sum of 3 quarters · filed 2025-05-14 | $5.94M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.26M derived: sum of 2 quarters · filed 2025-03-27 | $4.24M derived: sum of 3 quarters · filed 2025-03-27 | $5.97M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $1.09M 10-Q · filed 2024-11-13 | $1.11M 10-Q · filed 2023-11-14 | $3.07M derived: sum of 2 quarters · filed 2024-11-13 | $4.80M 10-Q · filed 2024-11-13 | $4.90M 10-Q · filed 2023-11-14 | $5.62M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $1.98M 10-Q · filed 2024-08-13 | $2.01M 10-Q · filed 2023-08-14 | $3.71M 10-Q · filed 2024-08-13 | $3.79M 10-Q · filed 2023-08-14 | $4.54M derived: sum of 3 quarters · filed 2024-08-13 | $5.26M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $1.73M 10-Q · filed 2024-05-14 | $1.78M 10-Q · filed 2023-05-15 | $2.56M derived: sum of 2 quarters · filed 2024-05-14 | $3.28M derived: sum of 3 quarters · filed 2024-05-14 | $3.88M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.55M derived: sum of 2 quarters · filed 2024-04-16 | $2.15M derived: sum of 3 quarters · filed 2024-04-16 | $2.50M 10-K · filed 2024-04-16 | $2.82M 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $727.00K 10-Q · filed 2023-11-14 | $1.32M derived: sum of 2 quarters · filed 2023-11-14 | $1.68M 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | $596.00K 10-Q · filed 2023-08-14 | $951.00K 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $355.00K 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | $2.77M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |